Drugs for Type 2 Diabetes: Second- and Third-Line Therapy Review Update

CADTH has completed its Therapeutic Review update of second-line therapies for patients with type 2 diabetes. The following reports are now available on the CADTH website:

• final science report on second-line therapy (clinical and economic evaluations)
• final recommendations report on second-line therapy

Supporting documents:

• In Brief — a summary of the project including key messages
• Project Protocol
• Patient Input

Work is underway at CADTH on the third-line therapy review. Stay tuned for opportunities to provide feedback.

For more information, visit the project page at www.cadth.ca/newdrugst2dm.